5,12-Naphthacenedione, 8-acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-[3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-
-
5,12-Naphthacenedione, 8-acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-[3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-
structure -
-
CAS No:
50935-05-2
-
Formula:
C33H41NO13
-
Chemical Name:
5,12-Naphthacenedione, 8-acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-[3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-
-
Synonyms:
5,12-Naphthacenedione,8-acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-[3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-;Carminomicin 2;Carminomycin II;75804-90-9
-
CAS No:
Description
A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata.
5,12-Naphthacenedione, 8-acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-[3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy- Basic Attributes
659.7 g/mol
659.68
Drug Information
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)|Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
Carminomicin
Computed Properties
Molecular Weight:659.7
XLogP3:1.9
Hydrogen Bond Donor Count:7
Hydrogen Bond Acceptor Count:14
Rotatable Bond Count:10
Exact Mass:659.25779036
Monoisotopic Mass:659.25779036
Topological Polar Surface Area:236
Heavy Atom Count:47
Complexity:1160
Undefined Atom Stereocenter Count:9
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
5,12-Naphthacenedione, 9-ethyl-7,8,9,10-tetrahydro-6,9,11-trihydroxy-7-[[2,3,6-trideoxy-3-(4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-, (7S,9S)-
132098-65-8
-
5,12-Naphthacenedione, 8-acetyl-10-[[3-[bis-(phenylmethyl)amino]-2,3,6-trideoxy-.α.-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-
70878-51-2
-
5,12-Naphthacenedione, 8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
66900-32-1
-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-4,6,9,10-tetrahydroxy-1,8-dimethoxy-9-methyl-7-[[2,3,6-trideoxy-3-(dimethylamino)-3-C-methylhexopyranosyl]oxy]- Formula
205752-47-2
-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-β-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI) Formula
57819-80-4
-
5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,6,7,8,11-pentahydroxy-10-[[2,3,6-trideoxy-3-(4-morpholinyl)hexopyranosyl]oxy]-, hydrochloride (1:1), (7R,8R,10S)- Formula
131722-57-1
-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(diethylamino)-.α.-L-lyxo-hexopyranosyl]oxy]-, hydrochloride, (8S-cis)- Structure
70844-09-6
-
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(N-L-leucyl-L-alanyl)amino]-α-L-xylo-hexopyranosyl]oxy]-, monohydrochloride, (8S-cis)- Structure
74853-79-5
-
What is 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(1-hydroxyethyl)-10-[[2,3,6-trideoxy-3-(formylamino)-α-L-lyxo-hexopyranosyl]oxy]-, (8S-cis)-
76634-96-3
Request for Quotation